MedPath
HSA Approval

Mirtazapine Sandoz Orodispersible Tablets 30mg

SIN13644P

Mirtazapine Sandoz Orodispersible Tablets 30mg

Mirtazapine Sandoz Orodispersible Tablets 30mg

May 4, 2009

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, ORALLY DISINTEGRATING

ORAL

Medical Information

N06AX11

mirtazapine

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Sandoz Private Limited

Active Ingredients

Mirtazapine

30.0mg

Mirtazapine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mirtazapine Sandoz Orodispersible Tablets 30mg - HSA Approval | MedPath